Neocytolysis: none, one or many? A reappraisal and future perspectives by Angela Risso et al.
REVIEW ARTICLE
published: 14 February 2014
doi: 10.3389/fphys.2014.00054
Neocytolysis: none, one or many? A reappraisal and future
perspectives
Angela Risso1, Annarita Ciana2, Cesare Achilli 2, Guglielmo Antonutto3 and Giampaolo Minetti2*
1 Department of Agricultural and Environmental Sciences, University of Udine, Udine, Italy
2 Laboratories of Biochemistry, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy
3 Department of Medical and Biological Sciences, University of Udine, Udine, Italy
Edited by:
Anna Bogdanova, University of
Zurich, Switzerland
Reviewed by:
Lawrence Rice, Houston Methodist
Hospital, USA
Josef Prchal, University of Utah,
USA
*Correspondence:
Giampaolo Minetti, Laboratories of
Biochemistry, Department of
Biology and Biotechnology “Lazzaro
Spallanzani,” University of Pavia,
Via Bassi, 21, 27100 Pavia, Italy
e-mail: minetti@unipv.it
Neocytolysis is the hypothesis formulated to explain experimental evidence of selective
lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma
levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC
mass reduction is required, i.e., in astronauts during the first days of spaceflight under
weightlessness, where a fast reduction in plasma volume and increase in haematocrit
occur. EPO plasma levels then decline and a decrease in RBC mass takes place,
apparently because of the selective lysis of the youngest, recently generated RBCs
(neocytes). The same process seems to occur in people descending to sea level after
acclimatization at high altitude. After descent, the polycythaemia developed at high
altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is
obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs.
In vivo, neocytolysis seems to be abolished by EPO administration. More recent research
has ascribed to neocytolysis the RBC destruction that occurs under such disparate
pathophysiologic conditions as nephropathy, severe obstructive pulmonary disease, blood
doping, and even malaria anaemia. According to the theory, EPO’s central role would be
not only to stimulate the production of new RBCs in conditions of anaemia, as maintained
by the orthodox view, but also that of a cytoprotective factor for circulating young RBCs.
Why neocytes are specifically destroyed and how is this related to decreased EPO levels
has not yet been elucidated. Changes in membrane molecules of young RBCs isolated
from astronauts or mountain climbers upon return to normal conditions seem to indicate
a higher susceptibility of neocytes to ingestion by macrophages. By limiting the context
to space missions and high altitude expeditions, this review will address unresolved and
critical issues that in our opinion have not been sufficiently highlighted in previous works.
Keywords: neocytolysis, erythropoietin, red cell lifespan, red cell mass regulation, red cell senescence,
microgravity, space flight, mountaineering
INTRODUCTION
The red blood cells (RBCs) of mammals are non-nucleated cells
that spend in the circulation a limited amount of time, after which
they are removed by the reticulo-endothelial system according to
a species-specific type of kinetic. This results from the superim-
position of random destruction (independent of cell age) and of
a senescence process. The magnitude of the random component
varies in different species and in different animals within the same
species. It is very pronounced in mice and rats, less pronounced
in pigs, rabbits and other mammalians, and almost absent in nor-
mal humanRBCs, which are recognized as senescent and removed
after 120 days of circulatory life (Clark, 1988; Landaw, 1988;
Brovelli and Minetti, 2003). In various haematological disorders
the destruction of poorly deformable or otherwise compromised
RBCs occurs at a faster rate, with spleen as the main organ
involved in the process, since splenectomy often alleviates the
abnormal shortening of life-span of these cells (Landaw, 1988).
On the other hand, it is believed that the spleen has only a mod-
est role in the removal of normal senescent RBCs, which were
shown to be phagocytosed almost exclusively in the bone marrow
(Miescher, 1956; Marton, 1970; Clark, 1988; Landaw, 1988). The
mass of RBCs (RBCM) circulating at each given time is the result
of a dynamic balance between the destruction of old cells and the
production of new ones, which derive from precursors of the ery-
throid lineage. The production of precursors is regulated, in its
early phase, by various factors, among which are erythropoietin
(EPO), that maintains cell vitality and transmits anti-apoptotic
signals, and SCF (stem cell factor), a proliferation factor (Jacobs-
Helber et al., 1997; De Maria et al., 1999). At later stages, primary
erythroblasts proceed through their proliferation and differentia-
tion programs, thanks to other factors, among which osteopontin
appears to play a central role as a factor of proliferation and
remodeling of the cytoskeleton (Kang et al., 2008). On the other
hand, it is an accepted view that, under physiologic conditions, no
mechanisms exist (or are not known), which are able to decrease
the RBC life-span below an established, fixed value, which, in
humans, amounts to the said 120 days (corresponding to the
removal of approximately 1% RBCs per day).
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THE NEOCYTE AND NEOCYTOLYSIS
The neologism “neocyte” was firstly adopted in the con-
text of transfusion medicine in the late 70s, when possi-
ble improvements in the transfusion regimens for patients
with haemoglobinopathies (particularly thalassemia) were under
intensive study, and one approach was based on the infusion of
“neocytes” (then defined as the 50% less dense circulating RBCs,
which were also assumed to comprise the youngest RBCs) with
higher survival rate, with the aim at reducing the frequency of
transfusions, and thus iron overload, in these patients (Propper
et al., 1980). More recent evidence has shown, however, that the
infusion of neocytes is less advantageous than expected (Pisciotto
et al., 1986), and it is nowadays not practiced on a large scale for
the long-term treatment of patients (Forget and Olivieri, 2003).
The term “neocytes” has been adopted again, more recently
and in an entirely different context, with the theory proposed
by Alfrey and co-workers to explain the anaemic condition that
affects astronauts after space flights (“space anaemia”) (Alfrey
et al., 1997). In 1965, a study showed that in astronauts partic-
ipating in orbital flights Gemini IV, V, and VII, a decrease in
erythrocyte survival and in RBCM was occurring, due to ery-
throlysis of unknown cause (Fischer et al., 1967). On escaping
the Earth’s gravitational force the human organism experiences
a reduction in total blood volume, plasma volume (PV) and,
most importantly, of RBCM. The peripheral blood normally held
in place by gravity, moves to central organs where a condition
of acute plethora ensues. At the same time, a 20% reduction in
PV takes place by redistribution in various compartments, thus
inducing an increase in haematocrit (“pseudopolycythaemia”)
(Watenpaugh, 2001; De Santo et al., 2005). In the following days,
a drop in EPO levels is observed, along with a decrease in RBCM
of 10–15%, that has been likened to a phlebotomy of 700ml of
blood (Figure 1). According to the neocytolysis hypothesis, the
latter decrease occurs too rapidly to be only the result of combined
suppression of erythropoiesis and continued, normal destruction
of physiologically aged RBCs (occurring at a rate of less than 1%
per day), but could be explained by the selective lysis of relatively
young RBCs, the “neocytes.”
Neocytolysis would effect a finely-tuned and rapid regula-
tion of the RBCM for a more efficient adaptation to mutated
environmental conditions such as the following situations: in
high-altitude dwellers (alpinists in mountaineering expeditions)
returning to a normoxic environment at sea level; in anaemic
uraemic patients requiring therapy with exogenous EPO (Rice
et al., 1999); in patients with combined kidney and heart failure
where a resistance to EPO treatment has been described to occur
frequently (De Santo et al., 2005; van der Putten et al., 2008);
and in a human model based on cycles of EPO injection and
withdrawal (Rice and Alfrey, 2005). Moreover, the neocytolytic
process could be relevant in other contexts as polycythaemia vera,
blood-doping in sports, haemolytic anaemias (Mentzer et al.,
1971), in patients with severe chronic obstructive pulmonary
disease when subjected to oxygen therapy, where neocytolysis
would occur upon therapeutic relieving of the hypoxic condi-
tions (Harris and Epstein, 2001), and for the development of
malaria anaemia, as recently proposed (Fernandez-Arias et al.,
2013).
FIGURE 1 | Representation of central blood pooling in space. Upon
transition from normogravity (A) to microgravity (B) the blood of the
peripheral vascular space shifts to central space, causing central acute
plethora, accompanied by peripheral vessel constriction. An adjustment is
obtained by reduction of PV and RBC mass through erythrolysis and EPO
reduction (C) over the first days of spaceflight. Then, upon return to
normogravity (D), the normal redistribution of blood volume and the
augmentation of blood fluid reduce the haematocrit (space anemia). From
Charles et al. (1994).
Comprehensive and stimulating reviews and commentaries
have appeared that deal with neocytolysis, some from the same
researchers who proposed the theory (Alfrey et al., 1997; Rice
and Alfrey, 2000, 2005; Alfrey and Fishbane, 2007), some by
others (Means, 1999; Harris and Epstein, 2001; De Santo et al.,
2005; Handelman and Levin, 2010). We will limit this review to
address some unresolved issues that in our opinion have not been
sufficiently highlighted in previous works, and limit the focus
on the experimental evidence obtained in space missions and
high-altitude expeditions, the context where the theory was orig-
inally formulated, in particular in relation to the establishment
of the link between EPO withdrawal and the removal of selected
subpopulation(s) of RBCs.
EXPERIMENTAL EVIDENCE OF THE NEOCYTOLYTIC PROCESS
IN SPACE MISSIONS
A decrease in RBCM of variable amounts was a consistent find-
ing in astronauts during space flights. It was originally imputed
to oxidation-induced haemolysis or oxygen inhibition of ery-
thropoiesis, because an atmosphere of pure oxygen was breathed
aboard of Gemini or Apollo missions. It was however observed
also in subsequent missions where the atmosphere was simi-
lar to air at sea level, pointing therefore to a gravity-dependent
mechanism capable of altering RBC survival. Evidence of ery-
tholysis under microgravity came from studies on Spacelab Life
Sciences missions 1 and 2 (SLS-1 and SLS-2) (Udden et al.,
1995; Alfrey et al., 1996a). Results showed unequivocally a reduc-
tion in RBCM, as measured, at landing, by radionuclide dilution
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techniques with 51Cr-labeled autologous RBCs and 125I-iodinated
albumin. When data from two other missions (Spacelab-1 and
Space Transport System 41-B) were also considered, RBCM
reduction was linearly correlated with mission length, and the
extrapolation to day zero of flight suggested a faster RBCM
decrease during the first days of flight (Alfrey et al., 1996a). On
the first day of flight, PV also decreased by a significant 17%, with
respect to values measured on 2 pre-flight days, thanks to the
egress of albumin-containing fluid from the vascular space (the
reasons for this are by no means clear, see Watenpaugh, 2001),
and the establishment of a condition of “acute plethora” ensued
(Figure 1).
Peripheral blood parameters revealed increased RBC con-
centration in-flight, of approximately 20%, which was related
to the concomitant decrease in PV (Alfrey et al., 1996a). The
microhaematocrit measured in-flight by centrifugation did not
increase, despite the fall in PV, and this was explained with the
observed concomitant decrease in MCV (calculated from RBC
concentration and haematocrit). The explanation was that the
number of young cells, which are larger, was decreasing. Crew
members were sampled as early as day two in-flight, and every
other day until flight day 14, but it is not clear how early the MCV
decrease began (Alfrey et al., 1996a). The question is not trivial
because it could help distinguish between a true selective removal
of young RBCs and a generalized decrease in cell volume or the
shrinkage of a subpopulation of cells, perhaps still, but not neces-
sarily, the youngest circulating cells. To the best of our knowledge,
no other study published or commented on MCV values mea-
sured during space missions, except for a decrease from pre-flight
values of 90.9 ± 3.1 to 89.3 ± 2.8 fL (statistically significant
despite the small difference) recorded at landing in 11 astronauts
of the International Space Station Expeditions 1–8 (2000–2004)
(Smith et al., 2005), but these were long-term missions (128–195
days), where compensatory processes appear to reset the home-
ostatic mechanisms and alleviate even the reduction in RBCM
(Tavassoli, 1982).
The other important measured haematological parameter was
EPO, whose levels decreased significantly, by about 25%, but only
at days 2–4 in-flight, to return normal at flight days 8–12 (Alfrey
et al., 1996a). In the previous SLS-1 study of three crew members,
EPO levels were constantly 31% lower in-flight, but the mission
only lasted 9 days (Udden et al., 1995).
The ferrokinetic data obtained by injecting 59Fe 22 h or 72 h
after launch for SLS-1 and SLS-2, respectively, and measuring the
radiolabel in plasma and in RBCs, indicated that new RBC pro-
duction in the bone marrow was not decreased from pre-flight
values, and therefore this could not account for the magnitude of
the decrease in RBCM (Alfrey et al., 1996b). New RBC production
was not unexpected in SLS-1, where 59Fe was injected after 22 h
in-flight, because, despite the transient EPO decrease, committed
erythroid precursors that were conceived before the labeling will
continue to mature and will be released in the circulation during
flight. For this reason, in SLS-2 radioiron was injected after 72 h
in-flight. In this case, too, results indicated a normal RBC pro-
duction. But SLS-2 is the mission where EPO levels returned to
normal at flight day 8. Nonetheless, Authors concluded that the
decrease in RBCMmust have originated from an accelerated RBC
destruction with respect to the physiological value (approximately
1%/day).
Reticulocyte counts (expressed as percent of RBCs) were only
mentioned in the text for SLS-1, and were found to be decreased,
for each crew member, with an average for all subjects of 0.6%
on landing, after 9 flight days, with respect to 1% before the
flight. Unfortunately, reticulocyte counts were not given for SLS-
2, which would have allowed refining the definition of neocytes
as including or not the reticulocytes (see below). Available data
on reticulocytes in two Gemini VII astronauts showed no change
between pre-flight values and landing and 2 days post-flight val-
ues. However, changes in haematological parameters and RBCM
in Gemini missions were in part (and demonstrably) determined
by hyperoxia conditions (Fischer et al., 1967; Tavassoli, 1982).
Reticulocyte data are available also for the four crew members
of the 10-day Spacelab 1 mission in 1984 (Leach and Johnson,
1984). Strangely, the reticulocyte counts were significantly lower,
by approximately 50%, already the day before launch, with respect
to pre-flight values (taken 1 week before flight), and, after an
apparent return to values only 17% lower than baseline (non-
significantly) at flight day 1, they were significantly 50% lower
than baseline again at flight day 7. Interestingly, only the latter
statistical significance was taken into account, whereas the for-
mer was disregarded as the result of “such factors as stress and
previous blood withdrawals” (incidentally, previous blood with-
drawals should increase, not increase reticulocyte counts) (Leach
and Johnson, 1984). Additional results of this work showed that
EPO levels did not change, and that RBCM decreased by about
1%/day, concluding that inhibition of erythropoiesis was not
the only cause of RBCM reduction. Subsequently, however, EPO
concentrations were correctly measured, with a newly available
radioimmunoassay, in samples from the same mission and were
found to be significantly decreased from flight day 1 until landing
of that relatively short space mission (7 days) (Leach et al., 1988).
Other confounding factors in erythrokinetic studies include
the ferritin status during and after space flight. Serum ferritin
has been found increased after many long-term and short-term
spacemissions (Smith et al., 2001), an indication of increased iron
storage resulting from the destruction of RBCs (neocytes?) tak-
ing place during flight. However, it is well known that increases
in serum ferritin may also derive from inflammatory or gen-
eral stress response. To overcome this limitation, iron content in
ferritin should be quantified. Measurements of this kind in astro-
nauts returning from long-termmissions have revealed a decrease
in ferritin saturation despite the increase in serum ferritin (Smith
et al., 2001, 2005). On the other hand, the concentration of circu-
lating transferrin receptors (which decreases with iron load) was
decreased in one study (Smith et al., 2001) but not significantly
decreased in a more comprehensive subsequent report (Smith
et al., 2005).
RANDOM LABEL METHODWITH 51Cr FOR EVALUATING RBC
DESTRUCTION
Stronger evidence for an increased destruction of young RBCs in
space came from the 51Cr random labeling studies performed on
six astronauts participating in the NASA shuttle missions SLS-1
and SLS-2. Here, autologous RBCs from six crew members from
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each mission were labeled with 51Cr and reinjected intravenously
21 days (SLS-1) or 12 days (SLS-2) before launch. Samples were
then taken at intervals during the flight to determine the 51Cr spe-
cific activity, i.e., the counts per minute per millilitre RBCs. The
percent change in 51Cr specific activity with respect to the value
at time of injection was used as an estimate of RBC production
and survival (Alfrey et al., 1996a).
Results showed that, after launch, the specific activity increased
over that predicted had the astronauts remained on Earth. On
landing day the mean difference was 6% more than predicted for
the crew members, resulting from a much slower rate of change
in specific activity in the first 4 days of flight with respect to
that measured before flight (Figure 2). From data obtained in the
SLS-2 mission the Authors concluded that the relative increase
in 51Cr specific activity was the result of a selective decrease in
unlabeled cells, those produced in the days before flight, after the
radiolabeling, and during flight, and not only the consequence
of decreased erythropoiesis (due to the decrease in EPO) com-
bined with normal RBC destruction rate. Interestingly, when data
obtained in the SLS-1 mission were originally published (Udden
et al., 1995), it was concluded that erythropoiesis was partially
inhibited because the ferrokinetic study with 59Fe revealed a lower
incorporation of 59Fe into RBCs and that the observed 11%
decrease in RBCM was the result of suppressed release of RBCs
into the circulation (it was speculated that EPO could have a role
in permitting the egress of RBCs for the bone marrow) together
with the normal age-related destruction of circulating RBCs at
the physiological rate of 1%/day (Udden et al., 1995). In fact, in
the SLS-2 mission the decrease in RBCM was more pronounced,
FIGURE 2 | Red cell survival on SLS-2 space mission. Data points are a
composite of results from three astronauts. Red cell survival is normal
pre-launch whereas the inflection in the curve beginning at launch has been
interpreted as the result of destruction of unlabeled erythrocytes
(neocytes), and a consequent increase in the concentration of labeled cells.
The last point (square symbol) is based on the measured chromium
remaining, corrected for the cell mass measured on landing day. The fact
that the trend line (dashed line) generated from preflight values transects
this point demonstrates that older labeled red cells are removed from the
circulation at the same normal rate in space as on Earth. Redrawn from
Rice and Alfrey (2005).
and could not be explained only by the physiological rate of RBC
removal and the relatively modest suppression of erythropoiesis
(Alfrey et al., 1996a).
The rate of disappearance of the 51Cr label from blood is
determined by the rate at which new cells enter the circulation
combined with the rate of elution of 51Cr from the labeled RBCs.
The method and the data obtained in space missions are valid
only under the assumption that the rate of elution of 51Cr from
labeled RBCs is the same in space, under conditions of plethora
and dramatic shifts in body fluids, as is on Earth. The Authors
were conscious of this when they stated “If the rate of 51Cr elu-
tion is assumed to be unaffected by spaceflight. . . ” (Udden et al.,
1995). However, as the rate of elution is known to vary amply,
with an average of 1% per day under physiological conditions
(Bentley et al., 1974), but with a much broader range of between
0.62 and 2.27% per day under pathological conditions (Cline and
Berlin, 1963), one cannot but wonder what would be the situation
under conditions of microgravity. In other words, a decrease in
the steepness of the curves of 51Cr disappearance from the circu-
lation (Alfrey et al., 1996a) could be also explained by a decreased
elution of the 51Cr label taking place, for whatever reasons, as
soon as the organism is exposed to microgravity conditions.
Another aspect that has not been sufficiently considered in the
neocytolysis theory (but was contemplated in early studies, see
Fischer et al., 1967) is the possible selective sequestration of young
RBCs to other compartments, e.g., the spleen.
Before the advent of the neocytolysis hypothesis, interesting
data on RBC survival were obtained from studies in rats aboard
the Soviet Biosatellite Kosmos 782 and 936 (Leon et al., 1978,
1980). Here, a cohort-labeling method was used by feeding the
animals 14C-glycine 19 days before flight, and quantifying the res-
piratory 14CO, derived from heme catabolism, starting at day 2
from landing. Unlike the random labeling with 51Cr, this pro-
cedure is in principle immune from elution of the label, since
only the 14C biosynthetically incorporated into heme is measured
(Landaw and Winchell, 1970). A number of parameters can be
calculated, including the rate of random cell death and the rate
of cell death by senescence (Leon et al., 1980). It turned out that
the rate of random cell death of RBCs was higher in rats dur-
ing space flight with respect to both a control group on Earth
and, most notably, a group of rats that were exposed to simu-
lated 1 g gravity on an on-board centrifuge. This was the first
piece of evidence pointing to weightlessness as the cause of RBCM
reduction, and excluding a number of possible factors such as
hyperoxia, radiation, forces associated with launch and re-entry,
temperature and humidity, diet. An increased rate of random
destruction, and the consequent decrease in RBC death by senes-
cence, together with the fluid shifts and central plethora (that may
occur also in rats, as hypothesized, but not verified, by the Authors
of this work) suggested on the one hand that RBCM reduction
resulted from accelerated haemolysis, not only from suppressed
erythropoiesis and normal destruction rate, and on the other,
that the fluid shifts could change splenic function leading to
increased sequestration and haemolysis in this organ (Leon et al.,
1980). Another hypothesis, brought on by Tavassoli (1982) was
that intramedullary haemolysis or selective lysis of reticulocytes
(neocytes?) could explain the data of Leon et al. on rats. On the
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other hand, random destruction, by definition, affects RBCs inde-
pendently from cell age, and moves the focus on altered splenic
function rather than specific cell properties. Because in these
works on rats EPO concentrations were notmonitored, an impor-
tant parameter is missing, making it difficult to rationalize the
data. Another important aspect is whether or not a plethora of
the same magnitude as the one observed in humans also occurs
in small animals exposed to microgravity (Figure 3).
A causal relationship was established (although only at a spec-
ulative level for the moment), between the disappearance of a
young RBC subpopulation and the transient decrease in EPO
observed during flight. It will be now examined on the basis of
what experimental evidence this concept was extended to other
models of physiological adaptive response and whether the causal
relationship between neocytolysis and EPO decrease, which are so
far only correlated events, was corroborated.
NEOCYTOLYSIS AFTER DESCENT FROM HIGH ALTITUDE
Since, more than 60 years ago, Merino (1950), analysing erythro-
poiesis in people living at high altitude (4540m a.s.l.), described a
decreased production and an increased destruction of RBCs dur-
ing the deacclimatization at sea level, these observations remained
obscure until 2001, when results of a study were published sup-
porting the notion that neocytolysis is triggered also on descent
from high altitude.
In this study (Rice et al., 2001), nine men living at 4380m
a.s.l. and polycythaemic (as expected for people living there)
were analyzed for a baseline period of 11 days at high altitude
and for additional 9 days after descent. Five blood samples were
taken at altitude and four samples at sea level for analysis of
various haematological parameters: haematocrit, haemoglobin
concentration, reticulocytes, serum EPO, serum ferritin, serum
FIGURE 3 | Effects of terrestrial gravity on the cardiovascular system:
the upright position. The impact of microgravity affects 70 and 30% of
blood volume in humans and dogs, respectively. From Rowell (1983).
transferrin receptor and heme isolation. In this study, to differen-
tiate between young and old cells a cohort-labeling method, dif-
ferent from the 51Cr random-labeling, was adopted. Participants
ingested 1 g of 13C-glycine on day 1 of the study and 1 g of 15N-
glycine on day 9. Blood and stool specimens were then analyzed
for 13C and 15N enrichment in heme and stercobilin. Three par-
ticipants were injected subcutaneously with 1200 U EPO daily
beginning on the day of descent. Upon descent to sea level,
serum EPO levels were decreased by approximately 80% in the
six participants who did not receive exogenous EPO.
The average decrease in RBC mass was 7.0–9.6% within 3–7
days of descent. In the legend to the figure reporting those data,
however, it is said that the measurements were performed “after
10 days at sea level.” (Rice et al., 2001). It must be considered
here that a decrease of RBCM of 7–9.6% in 7 days is close to the
physiological value of RBC destruction under conditions where
RBCs are not replaced by new ones (EPO levels decreased in these
subjects by an average 80%, much more than in space missions).
Concerning the isotopic enrichment in heme and stercobilin,
the latter could not be determined because of low isotope lev-
els, whereas the former was reported as being compatible with
a decrease in young red cells at descent, although the differences
were not statistically significant. Therefore, the main argument
of the paper in favor of young RBC destruction was based on
the observed elevation of ferritin levels, which was interpreted
as the transfer of iron to stores. However, ferritin saturation was
not measured, and this, combined with the observation that the
levels of circulating transferrin receptors did not change, raises
the suspicion that ferritin might have been elevated for other rea-
sons (see above the discussion on these two parameters in space
missions).
Another piece of evidence presented as a strong argument in
favor of a haemolytic process triggered by descent to sea level
was the observation that reticulocyte counts did not change with
respect to baseline values (120± 52× 109 cells/L at baseline vs.
141± 52× 109 cells/L during the first 6 days at sea level). Only
on day 8 at sea level did the reticulocyte counts decrease to 90±
54× 109 cells/L, a delayed decrease that was correctly interpreted
as the response to continued EPO suppression (remembering that
reticulocytes released in the circulation at day 6 after descent were
conceived in the bone marrow 6 days earlier in the presence of
normal EPO levels). However, what is hard to reconcile with the
neocytolysis hypothesis is that during the days when neocytoly-
sis should be at its zenith, because plethora is at a maximum and
EPO levels at the nadir, i.e., during the first week at sea level, the
reticulocytes are spared by the process, as if they were something
different from the neocytes. Yet, the Authors concluded: “that the
decrease in red cell mass while reticulocyte production remained
normal provides conclusive evidence of a haemolytic process”
(Rice et al., 2001). Evidently, different features in the reticulo-
cyte and neocyte must be invoked to accept this explanation, but
a discussion about this aspect has never been conducted. Results
of reticulocyte measurements in space missions (see above) and
in descent from altitude are inconsistent and probably not infor-
mative of underlying changes in erythrokinetics. Mechanisms
for the selective removal of RBCs produced under conditions of
acutely enhanced erythropoiesis (stress reticulocytes) may also
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be invoked (Landaw, 1988) but this explanation, while possi-
bly applicable to RBCs produced at high altitude under hypoxic
conditions, does not obviously work for space anaemia, where
neocytes that were produced before flight (i.e., under normal,
physiological conditions) are supposed to be destroyed.
It should be also mentioned results of a research where, after
a 9 day training at 1900m a.s.l. and return to sea level of eight
elite endurance cyclists, total reticulocyte counts were slightly
decreased, whereas the population of immature reticulocytes
(detected as high- and medium- fluorescent cells in the analyt-
ical procedure) appeared to better reflect the changes in RBC
production and destruction before and after descent, with a pat-
tern compatible with an undergoing neocytolytic process (with all
the limitations of the study, which include short acclimatization
period, relatively modest altitude and high variability of the data)
(Nadarajan et al., 2010).
EXPERIMENTS ON RBCs SUBSETS
The experiments conducted in vivo, through determination of
haematological parameters on high altitude dwellers or astro-
nauts gave conflicting and incomplete results, partially due to
reasons inherent to this type of experiments, including the small
number of subjects examined, which prevent any robust statis-
tical analysis, and the environmental constraints the approach
imposes. Blood withdrawal in space or at high altitude can be
uneasy; furthermore, the storage of samples in space or at high
altitude, with limited laboratory facilities, could alter the prop-
erties of the blood components. Finally, a further bias of the
systemic approach is the non-univocal interpretation of some
haematological parameters whose alteration can be due to reasons
different from altered RBC mass and erythrolysis, as mentioned
above.
In an attempt to somehow circumvent this problem, we tried
to shift from a physiological, systemic approach to one at the
cellular and molecular level, by analysing blood samples drawn
before and after the exposure to microgravity or hypoxia, and by
separating RBCs by density into age-related fractions (Risso et al.,
2007, 2008).
A previous validation of the density separation procedure
(Risso et al., 2007), and a characterization of some membrane
components differentially expressed by old red cells, suggested
that the neocytolysis hypothesis could be challenged through
the investigation of the cell numbers and properties of the den-
sity separated subsets. Due to the technical constraints described
above, it was not possible to conduct parallel measurements of
4.1a/4.1b ratio (see below), to verify whether changes in cell
density that could occur on exposure to altered physiological
conditions affected a selected subpopulation of RBCs.
In both the astronauts and the mountain climbers groups,
after the exposure either to microgravity or high altitude, some of
the standard haematological and cellular parameters (decrease of
EPO plasma concentrations, increase in ferritin, decrease in retic-
ulocytes) related to erythrolysis, indicated that this process was
under way. In all subjects of both groups the percentage of low
density (neocytes) after vs. before (control blood samples) the
exposure to hypoxia or microgravity was reduced. The expres-
sion of membrane components which decline (CD55, CD47)
or are translocated to the outer leaflet of the membrane bilayer
(phosphatidylserine) in aged RBCs, and seem to be involved
in the positive or negative regulation of phagocytosis, indicated
that the less dense red cells (the few surviving neocytes) had a
senescent phenotype, making them more prone to ingestion by
macrophages (Risso et al., 2007, 2008).
In mountain climbers indeed a dramatic shift of the whole
RBC population to high density regions of Percoll gradients
seemed to indicate lysis also of many RBCs of the middle den-
sity (middle aged) subset and suggested a generalized increase in
density of the whole RBC population, raising some doubts on the
age-density relationship, at least under certain circumstances.
The observations on RBCs drawn from people adapted to
high altitude were extended to other biochemical features. The
ATP content of RBCs isolated during the deacclimatization from
hypoxia was significantly higher than that of the control popu-
lations. Furthermore, alteration in the membrane-skeleton was
found by a proteomic analysis, i.e., fragmentation of spectrin and
actin (Risso et al., 2010). Finally in an investigation on blood sam-
ples drawn from mountain climbers, over and immediately after
a 17 days’ time spent at 3100–5600m a.s.l., we observed that high
altitude induced the expression of foetal haemoglobin. Gamma
globin expression was detected in low but not in middle or high
density RBCs, when separated from samples drawn during and
after exposure to hypoxia (Risso et al., 2012). These observa-
tions, if on the one hand seem to suggest that also low density
RBCs separated from particular blood samples can be reasonably
regarded as a “neocyte-enriched” subset, on the other hand indi-
cate that the “neocytolytic process” over high altitude could be
related not only to a reduced EPO synthesis and to the need to
decrease RBCs mass, but also to their particular features. Under
the hypoxic stimulus, erythroid precursors likely generate RBCs
which are endowed with biochemical features more fit to hypoxia
and which, upon return to normoxia, should be cleared.
THE ROLE OF EPO
The role of EPO is controversial, in part for the reasons exposed
above, because if one accepts the idea that the decrease in
RBCM observed in microgravity and on descent from altitude
can be accounted for only by the physiological destruction of
1% RBCs/day under conditions of decreased EPO, then there
would not be an active, cytoprotective effect of EPO on circulat-
ing erythrocytes. The magnitude of RBCM deficit does however
appear to be larger than expected at least for space missions of
short duration (7–15 days), especially because EPO secretion is
not suppressed, but only decreased, and only temporarily. The
“space anaemia” condition is in fact described in haematology
textbooks and treatises but it seems that neocytolysis is not yet
received unanimously as the explanation for this phenomenon,
because the fluctuations in EPO levels occurring during space
flights are not considered sufficiently large to affect the RBCM
(Erslev, 2001).
Conversely, RBCM decline after descent from altitude appears
to be less dramatic, and compatible with a physiological rate of
RBC destruction under conditions of strongly decreased EPO
levels (see discussion above). It is tempting to speculate that
the decrease in RBCM occurring in space and on descent from
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altitude may only be apparently related to a common mecha-
nism. At any rate, to account for RBCM decrease under both
circumstances, a cytoprotective effect of EPO on circulating RBCs
or RBC subpopulations has been invoked. The abrogation of
any eryhrolytic process by EPO infusion in three mountain
dwellers (the subjects remained polycythemic and no haemato-
logical parameter changes related to erythrolysis were observed),
favors the hypothesis of an ongoing erythrolysis in the subjects
that were not treated with EPO, and a possible causal correla-
tion between EPO and lysis of (young) red cells (Rice et al., 2001),
suggesting in that case a protective role played by EPO.
The existence of cytoprotective effects of this haematopoietic
hormone on a variety of different cell types has been described
(Kowalczyk et al., 2011; Shin et al., 2012). A study of the complex
expression pattern of EPO receptors in primary human erythroid
precursors induced to differentiate to reticulocytes, revealed the
lack of EPO receptors, at least in these in vitro-differentiated retic-
ulocytes (Sawada et al., 1990; Broudy et al., 1991; Wickrema et al.,
1992). Mature erythrocytes were found to virtually lack EPO
receptors, although murine RBCs, specifically the 2% youngest
(less dense) RBCs, were found to express them (Mihov et al.,
2009). In human erythrocytes, EPO has been described to inhibit
a Ca2+-permeable cation channel, whose opening can be evoked
in vitro by hyperosmotic shock, via a mechanism implying the
binding of EPO to EPO receptors that were found to be present,
as 125I-EPO-binding sites, in an average number of six per cell
(Myssina et al., 2003). It must be observed, in the light of recent
evidence (Minetti et al., 2013), that care must be taken in avoiding
artefacts originated by contaminating granulocytes in RBC prepa-
rations, especially when a possible enrichment in contaminating
cells is produced when RBCs are sub-fractionated according to
density.
At systemic level, pleiotropic effects of EPO acting not only
as a haemopoietic hormone but also in the regulation of PV,
in interplay with the renin–angiotensin–aldosterone axis, have
been reported (Lundby et al., 2007). On the other hand, EPO
effects seem to be context-dependent, as EPO produced in brain,
liver, spleen, lung and testis (where EPO mRNA was detected)
is unable to substitute for renal EPO in chronic kidney disease,
and brain EPO seems to act locally as neuroprotector (Jelkmann,
2011). Other difficulties in accepting direct effects of EPO, medi-
ated by its receptor, in non-erythroid tissues include evidence that
after suppressing EPO receptor expression in all organs except
bonemarrow inmice, normal and fertile animals develop (Suzuki
et al., 2002), and that EPO receptors are undetectable in non-
haematopoietic cells (Sinclair et al., 2010; Jelkmann, 2011). On
the other hand, it was shown that erythropoietically inactive EPO
derivatives act as cytoprotective factors in animal models (Leist
et al., 2004). Would it be possible that EPO act, by molecu-
lar mimicry, on a different receptor system in other cell types,
including the RBC? Against this possibility is evidence that the
increased viability of peripheral RBCs measured with the 51Cr
random labeling technique in uraemic patients on recombinant
human EPO treatment was ascribed to molecular effects of EPO
on the erythroid precursor cells in the bone marrow, and not
on peripheral circulating erythrocytes (Polenakovic and Sikole,
1996).
Because of the inevitable scepticism with which claims of the
expression of EPO receptors in erythrocytes are met, it could be
hypothesized that the observed effect of EPO may be due to the
interference of EPO with other molecular targets in RBCs.
CONCLUSIONS
Neocytolysis is a physiological process which could shorten RBCs
lifespan in response to a changed external environment and lead
to a reduction in RBC mass. Despite many studies, the factors
determining the lifespan of cells (including RBCs) that circu-
late in blood are not fully understood. In the past years, in
red cells treated in vitro with some pro-apoptotic agents, a pro-
grammed cell death-like process has been described, which has
been dubbed eryptosis (Lang et al., 2008). Investigations on the
features and events associated with eryptosis have shown that
they are reminiscent of those already described in old senescent
red cells (dehydration, cell shrinkage, increase in cell density)
and of those observed in nucleated apoptotic cells [PS exposure,
increased intracellular Ca2+ concentration, altered functionality
of ion channels, see Lang et al. (2012)]. Then it appears that,
under some circumstances, RBCs death could be due to eryptosis.
Since RBCs lack the organelles and the multienzymatic, bio-
genic machineries able to protect the cells from external injuries,
they are particularly sensitive to any changes either of inner pro-
teins (altered haemoglobin, membrane lipid peroxidation, alter-
ation of membrane-skeleton) or of external signals perturbing
their homeostasis.
Within this framework, a shortening of lifespan is conceivable
whenever changes in haemoglobin (for instance, in thalassemia
or sickle cell disease) lead to alterations in membrane-skeleton,
cell shape, redox conditions, or changes in the external environ-
ment requiring a fast reduction of RBCM, speed up the pro-
grammed death (or senescence process), followed by macrophage
phagocytosis.
In this latter case, while reduction of RBCM has been docu-
mented in both exposure to microgravity and hypoxia, and some
data seem to indicate that erythrolysis is not at random, two
main issues need more detailed investigation: 1, the concomitant
decrease in EPO levels and RBCM, since, although a causal link
could be (and it has been) hypothesized, a formal evidence of this
relation is still lacking; and 2, the identification of the targeted
red cells. In relation to the latter argument, although the studies
on age-related subsets seem to indicate that the low- / middle-
density RBCs could be prone to phagocytosis, in view of their
“eryptotic” (or “senescent”) phenotype, the relation between low
density and age on the RBCs population after exposure to hypoxia
or microgravity is questionable.
Neocytolysis is a fascinating hypothesis that, for the rea-
sons exposed here, should be subjected to further scrutiny. It
would benefit from being tested with additional methods that
are immune from artefacts possibly arising from the different
conditions existing on Earth and under microgravity. One such
approach would be to conduct systematic and accurate measure-
ments of the RBC age parameter 4.1a/4.1b, which is an abso-
lute marker of RBC age independent on cell density, metabolic
activity or imponderable side effects of radiolabeling. It is a
molecular clock (Robinson and Robinson, 2004) whose ticking
www.frontiersin.org February 2014 | Volume 5 | Article 54 | 7
Risso et al. Critical analysis of neocytolysis and the role of erythropoietin
is only dependent on temperature, and therefore is relatively sta-
ble in a homeothermic animal. Measurements of 4.1a/4.1b could
be performed on the total population of circulating RBCs or
on cells separated by density. This approach yielded interesting
results when applied to the study of how cell age impacts on
RBC stored under blood bank conditions (Minetti et al., 2001).
Moreover, a more refined and rigorous definition of the neocyte
is required, because the reticulocytes are sometimes comprised
in this definition (space missions in general) and sometimes
not (descent form altitude). The difficulty in discovering (Chang
et al., 2009) molecular species in neocytes which could mediate
the response to decreased EPO levels, leading to recognition and
destruction of young RBCs, may be a symptom of the extremely
elusive nature of these species, depend on the necessity of imple-
menting a multicellular in vitro model (Trial et al., 2001; Trial
and Rice, 2004), suggest to look for off-target effects of EPO
(Jelkmann, 2011), or indicate the very absence of such molecular
machinery.
It would be worth restarting from what we know about RBCs
of different age. For instance, how the intracellular ion home-
ostasis and membrane permeability are regulated in response
to microgravity. Nothing is known of the calcium content or
permeability of RBCs (Bogdanova et al., 2013) in space. Young
RBCs have lower sodium and higher potassium and water con-
tent per-cell than older RBCs. There are several pathways that
can be activated and determine potassium efflux (Bernhardt and
Weiss, 2003). This could result in cell shrinkage, associated or
not with membrane vesiculation (Ciana et al., 2004; Willekens
et al., 2008), that could lead to reduction in deformability and the
appearance of a senescent phenotype in otherwise young RBCs.
A poorly deformable, dehydrated young erythrocyte would spend
more time in the spleen sinusoids, where it could be recognized as
abnormal and sequestered by the splenic macrophages. This is the
rationale for the indication of splenectomy to increase RBC sur-
vival in some pathological conditions. “Nothing is known about
splenic function in space” (Tavassoli, 1982), and it would be inter-
esting to verify whether neocytolysis could take place also in
splenectomized subjects. The possible occurrence of young RBC
shrinkage under microgravity is compatible with the observation
of the rapid decrease in MCV occurring in the 1st h of flight (see
above). On the other hand, no study has ever been conducted
on the impact of microgravity (in space or simulated) on RBC
membrane permeability (Prof. Dr. Ingolf Bernhardt, personal
communication).
Density separation of RBCs must be accompanied by deter-
mination of an absolute marker of cell age such as 4.1a/4.1b
ratio. This will help clarify our own results obtained in mountain
climbers after descent to sea level, where a massive shift in den-
sity profiles of RBCs from low to high density regions of Percoll
gradients were observed (Risso et al., 2007).
Combined measurements of 4.1a/4.1b ratio and density sep-
aration of RBCs could also shed light on such discrepancies as
the unclear behavior of reticulocyte counts, which were described
to decrease during flight, but were also found 50% lower the day
before flight (Leach and Johnson, 1984). Reticulocytes are prob-
ably not reliable indicators of the real size of the population of
young circulating RBCs.
Further studies are needed to establish whether the reduction
in RBCM, which is an established fact in a variety of blood disor-
ders or physiological adaptive responses, is due, in each condition,
to the removal of a selected population of RBCs, whether this is a
population of “neocytes,” and what are the features of the targeted
cells.
Given the complexity of the systemic responses, space anemia,
uraemic anemia and deacclimatization anemia could be unre-
lated processes altogether. Each should be re-examined in its own
context before generalizations could be made.
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